Clinical Trial Update: Prospective Evaluation of Artificial Intelligence-enabled Screening for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

View source ↗

Summary

A prospective study evaluating artificial intelligence-enabled screening for transthyretin amyloid cardiomyopathy (ATTR-CM). The trial status is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Transthyretin Amyloid Cardiomyopathy

Snippet

Sponsor: Yale University | Conditions: ATTR Amyloidosis With Cardiomyopathy, Heart Failure | Status: NOT_YET_RECRUITING